Epicardial fat inflammation response to COVID-19 therapies
CONCLUSIONS: Dexamethasone therapy was associated with significant reduction of EAT inflammation in COVID-19 patients, whereas SAT showed no changes. Anti-inflammatory therapies targeting visceral fat may be helpful in COVID-19 diseases.PMID:34028990 | DOI:10.1002/oby.23232
Source: Obesity - Category: Eating Disorders & Weight Management Authors: Gianluca Iacobellis Alexis Elias Malavazos Sara Basilico Silvia Tresoldi Rocco Francesco Rinaldo Carola Dubini Gloria Capitanio Francesca Serpi Simone Schiaffino Omar Alessandro Oliva Maurizio Cariati Lelio Morricone Stefano Centanni Francesco Sardanelli Source Type: research
More News: Actemra | Coronavirus | COVID-19 | CT Scan | Dexamethasone | Eating Disorders & Weight Management | Obesity